{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["melatonin", "multiple sclerosis", "myelin", "pyruvate dehydrogenase complex", "pyruvate dehydrogenase kinase"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30873027", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "02", "Day": "28"}], "Language": ["eng"], "ELocationID": ["147", "10.3389/fphar.2019.00147"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2019"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis.", "Pagination": {"StartPage": "147", "MedlinePgn": "147"}, "Abstract": {"AbstractText": ["Metabolic disturbances have been implicated in demyelinating diseases including multiple sclerosis (MS). Melatonin, a naturally occurring hormone, has emerged as a potent neuroprotective candidate to reduce myelin loss and improve MS outcomes. In this study, we evaluated the effect of melatonin, at both physiological and pharmacological doses, on oligodendrocytes metabolism in an experimental autoimmune encephalomyelitis (EAE) mouse model of MS. Results showed that melatonin decreased neurological disability scores and enhanced remyelination, significantly increasing myelin protein levels including MBP, MOG, and MOBP. In addition, melatonin attenuated inflammation by reducing pro-inflammatory cytokines (IL-1\u03b2 and TNF-\u03b1) and increasing anti-inflammatory cytokines (IL-4 and IL-10). Moreover, melatonin significantly increased brain concentrations of lactate, N-acetylaspartate (NAA), and 3-hydroxy-3-methylglutaryl-coenzyme-A reductase (HMGCR). Pyruvate dehydrogenase kinase-4 (PDK-4) mRNA and protein expression levels were also increased in melatonin-treated, compared to untreated EAE mice. However, melatonin significantly inhibited active and total pyruvate dehydrogenase complex (PDC), an enzyme under the control of PDK4. In summary, although PDC activity was reduced by melatonin, it caused a reduction in inflammatory mediators while stimulating oligodendrogenesis, suggesting that oligodendrocytes are forced to use an alternative pathway to synthesize fatty acids for remyelination. We propose that combining melatonin and PDK inhibitors may provide greater benefits for MS patients than the use of melatonin therapy alone."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CERVO Brain Research Center, Quebec City, QC, Canada."}, {"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Ghareghani", "ForeName": "Majid", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Platform of Research and Analysis in Sciences and Environment (PRASE), Lebanese University, Beirut, Lebanon."}, {"Identifier": [], "Affiliation": "INSERM U 1197, Laboratory of Stem Cells, Transplantation and Immunoregulation, Villejuif, France."}], "LastName": "Scavo", "ForeName": "Linda", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Jand", "ForeName": "Yahya", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Farhadi", "ForeName": "Naser", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Sadeghi", "ForeName": "Hossein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Ghanbari", "ForeName": "Amir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy."}, {"Identifier": [], "Affiliation": "Oasi Research Institute - IRCCS, Troina, Italy."}], "LastName": "Mondello", "ForeName": "Stefania", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "INSERM U 1197, Laboratory of Stem Cells, Transplantation and Immunoregulation, Villejuif, France."}], "LastName": "Arnoult", "ForeName": "Damien", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Bioinformatics and Drug Design, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran."}], "LastName": "Gharaghani", "ForeName": "Sajjad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Platform of Research and Analysis in Sciences and Environment (PRASE), Lebanese University, Beirut, Lebanon."}, {"Identifier": [], "Affiliation": "Biology Department, Faculty of Sciences-I, Lebanese University, Beirut, Lebanon."}], "LastName": "Zibara", "ForeName": "Kazem", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Altun A., Ugur-Altun B. (2007). Melatonin: therapeutic and clinical utilization. Int. J. Clin. Pract. 61 835\u2013845. 10.1111/j.1742-1241.2006.01191.x", "ArticleIdList": ["10.1111/j.1742-1241.2006.01191.x", "17298593"]}, {"Citation": "Alvarez-Sanchez N., Cruz-Chamorro I., Lopez-Gonzalez A., Utrilla J. C., Fernandez-Santos J. M., Martinez-Lopez A., et al. (2015). Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance. Brain Behav. Immun. 50 101\u2013114. 10.1016/j.bbi.2015.06.021", "ArticleIdList": ["10.1016/j.bbi.2015.06.021", "26130320"]}, {"Citation": "Batoulis H., Addicks K., Kuerten S. (2010). Emerging concepts in autoimmune encephalomyelitis beyond the Cd4/Th1 paradigm. Ann. Anat. 192 179\u2013193. 10.1016/j.aanat.2010.06.006", "ArticleIdList": ["10.1016/j.aanat.2010.06.006", "20692821"]}, {"Citation": "Bernardes D., Oliveira-Lima O. C., Silva T. V., Faraco C. C., Leite H. R., Juliano M. A., et al. (2013). Differential brain and spinal cord cytokine and Bdnf levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise. J. Neuroimmunol. 264 24\u201334. 10.1016/j.jneuroim.2013.08.014", "ArticleIdList": ["10.1016/j.jneuroim.2013.08.014", "24054000"]}, {"Citation": "Bjorkhem I., Meaney S. (2004). Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24 806\u2013815. 10.1161/01.ATV.0000120374.59826.1b", "ArticleIdList": ["10.1161/01.ATV.0000120374.59826.1b", "14764421"]}, {"Citation": "Brocke S., Gijbels K., Allegretta M., Ferber I., Piercy C., Blankenstein T., et al. (1996). Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379 343\u2013346. 10.1038/379343a0", "ArticleIdList": ["10.1038/379343a0", "8552189"]}, {"Citation": "Burri R., Steffen C., Herschkowitz N. (1991). N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev. Neurosci. 13 403\u2013411. 10.1159/000112191", "ArticleIdList": ["10.1159/000112191", "1809557"]}, {"Citation": "Cader S., Johansen-Berg H., Wylezinska M., Palace J., Behrens T. E., Smith S., et al. (2007). Discordant white matter N-acetylasparate and diffusion Mri measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis. Neuroimage 36 19\u201327. 10.1016/j.neuroimage.2007.02.036", "ArticleIdList": ["10.1016/j.neuroimage.2007.02.036", "17398118"]}, {"Citation": "Carmody R. J., Hilliard B., Maguschak K., Chodosh L. A., Chen Y. H. (2002). Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation. J. Neuroimmunol. 133 95\u2013107. 10.1016/S0165-5728(02)00366-1", "ArticleIdList": ["10.1016/S0165-5728(02)00366-1", "12446012"]}, {"Citation": "Chakraborty G., Mekala P., Yahya D., Wu G., Ledeen R. W. (2001). Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 78 736\u2013745. 10.1046/j.1471-4159.2001.00456.x", "ArticleIdList": ["10.1046/j.1471-4159.2001.00456.x", "11520894"]}, {"Citation": "Chen S. J., Huang S. H., Chen J. W., Wang K. C., Yang Y. R., Liu P. F., et al. (2016). Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis. Int. Immunopharmacol. 31 169\u2013177. 10.1016/j.intimp.2015.12.020", "ArticleIdList": ["10.1016/j.intimp.2015.12.020", "26735612"]}, {"Citation": "Dietschy J. M. (2009). Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol. Chem. 390 287\u2013293. 10.1515/BC.2009.035", "ArticleIdList": ["10.1515/BC.2009.035", "PMC3066069", "19166320"]}, {"Citation": "Fransen M., Lismont C., Walton P. (2017). The peroxisome-mitochondria connection: how and why? Int. J. Mol. Sci. 18:1126. 10.3390/ijms18061126", "ArticleIdList": ["10.3390/ijms18061126", "PMC5485950", "28538669"]}, {"Citation": "Fu L., Matthews P. M., De Stefano N., Worsley K. J., Narayanan S., Francis G. S., et al. (1998). Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121(Pt 1), 103\u2013113. 10.1093/brain/121.1.103", "ArticleIdList": ["10.1093/brain/121.1.103", "9549491"]}, {"Citation": "Funfschilling U., Supplie L. M., Mahad D., Boretius S., Saab A. S., Edgar J., et al. (2012). Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485 517\u2013521. 10.1038/nature11007", "ArticleIdList": ["10.1038/nature11007", "PMC3613737", "22622581"]}, {"Citation": "Ghareghani M., Dokoohaki S., Ghanbari A., Farhadi N., Zibara K., Khodadoust S., et al. (2017a). Melatonin exacerbates acute experimental autoimmune encephalomyelitis by enhancing the serum levels of lactate: a potential biomarker of multiple sclerosis progression. Clin. Exp. Pharmacol. Physiol. 44 52\u201361. 10.1111/1440-1681.12678", "ArticleIdList": ["10.1111/1440-1681.12678", "27696474"]}, {"Citation": "Ghareghani M., Sadeghi H., Zibara K., Danaei N., Azari H., Ghanbari A. (2017b). Melatonin increases oligodendrocyte differentiation in cultured neural stem cells. Cell. Mol. Neurobiol. 37 1319\u20131324. 10.1007/s10571-016-0450-4", "ArticleIdList": ["10.1007/s10571-016-0450-4", "27987059"]}, {"Citation": "Ghareghani M., Scavo L., Arnoult D., Zibara K., Farhadi N. (2018a). Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis. Fundam. Clin. Pharmacol. 32 181\u2013187. 10.1111/fcp.12337", "ArticleIdList": ["10.1111/fcp.12337", "29193274"]}, {"Citation": "Ghareghani M., Zibara K., Sadeghi H., Farhadi N. (2018b). Spasticity treatment ameliorates the efficacy of melatonin therapy in experimental autoimmune encephalomyelitis (eae) mouse model of multiple sclerosis. Cell. Mol. Neurobiol. 38 1145\u20131151. 10.1007/s10571-018-0580-y", "ArticleIdList": ["10.1007/s10571-018-0580-y", "29497878"]}, {"Citation": "Gressens P., Schwendimann L., Husson I., Sarkozy G., Mocaer E., Vamecq J., et al. (2008). Agomelatine, a melatonin receptor agonist with 5-Ht(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity. Eur. J. Pharmacol. 588 58\u201363. 10.1016/j.ejphar.2008.04.016", "ArticleIdList": ["10.1016/j.ejphar.2008.04.016", "18466899"]}, {"Citation": "Hagemeier K., Bruck W., Kuhlmann T. (2012). Multiple sclerosis - remyelination failure as a cause of disease progression. Histol. Histopathol. 27 277\u2013287.", "ArticleIdList": ["22237705"]}, {"Citation": "Hagenfeldt L., Bollgren I., Venizelos N. (1987). N-acetylaspartic aciduria due to aspartoacylase deficiency\u2013a new aetiology of childhood leukodystrophy. J. Inherit. Metab. Dis. 10 135\u2013141. 10.1007/BF01800038", "ArticleIdList": ["10.1007/BF01800038", "3116332"]}, {"Citation": "Hamdi A. (1998). Melatonin administration increases the affinity of D2 dopamine receptors in the rat striatum. Life Sci. 63 2115\u20132120. 10.1016/S0024-3205(99)80008-3", "ArticleIdList": ["10.1016/S0024-3205(99)80008-3", "9839535"]}, {"Citation": "Heidker R. M., Emerson M. R., Levine S. M. (2017). Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis. Neural Regen. Res. 12 1262\u20131267. 10.4103/1673-5374.213542", "ArticleIdList": ["10.4103/1673-5374.213542", "PMC5607817", "28966637"]}, {"Citation": "Hirrlinger J., Dringen R. (2010). The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking. Brain Res. Rev. 63 177\u2013188. 10.1016/j.brainresrev.2009.10.003", "ArticleIdList": ["10.1016/j.brainresrev.2009.10.003", "19883686"]}, {"Citation": "Husson I., Mesples B., Bac P., Vamecq J., Evrard P., Gressens P. (2002). Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann. Neurol. 51 82\u201392. 10.1002/ana.10072", "ArticleIdList": ["10.1002/ana.10072", "11782987"]}, {"Citation": "Inglese M., Ge Y., Filippi M., Falini A., Grossman R. I., Gonen O. (2004). Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage 21 1825\u20131829. 10.1016/j.neuroimage.2003.12.008", "ArticleIdList": ["10.1016/j.neuroimage.2003.12.008", "15050603"]}, {"Citation": "Jha M. K., Jeon S., Suk K. (2012). Pyruvate dehydrogenase kinases in the nervous system: their principal functions in neuronal-glial metabolic interaction and neuro-metabolic disorders. Curr. Neuropharmacol. 10 393\u2013403. 10.2174/157015912804143586", "ArticleIdList": ["10.2174/157015912804143586", "PMC3520047", "23730261"]}, {"Citation": "Johnson M. T., Mahmood S., Hyatt S. L., Yang H. S., Soloway P. D., Hanson R. W., et al. (2001). Inactivation of the murine pyruvate dehydrogenase (Pdha1) gene and its effect on early embryonic development. Mol. Genet. Metab. 74 293\u2013302. 10.1006/mgme.2001.3249", "ArticleIdList": ["10.1006/mgme.2001.3249", "11708858"]}, {"Citation": "Kalman B., Laitinen K., Komoly S. (2007). The involvement of mitochondria in the pathogenesis of multiple sclerosis. J. Neuroimmunol. 188 1\u201312. 10.1016/j.jneuroim.2007.03.020", "ArticleIdList": ["10.1016/j.jneuroim.2007.03.020", "17493689"]}, {"Citation": "Kang J. C., Ahn M., Kim Y. S., Moon C., Lee Y., Wie M. B., et al. (2001). Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1. J. Vet. Sci. 2 85\u201389. 10.4142/jvs.2001.2.2.85", "ArticleIdList": ["10.4142/jvs.2001.2.2.85", "14614276"]}, {"Citation": "Kawachi I., Lassmann H. (2017). Neurodegeneration in multiple sclerosis and neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry 88 137\u2013145. 10.1136/jnnp-2016-313300", "ArticleIdList": ["10.1136/jnnp-2016-313300", "27671902"]}, {"Citation": "Kehr J. (1999). \u201cMonitoring chemistry of brain microenvironment: biosensors, microdialysis and related techniques,\u201d in Modern Techniques in Neuroscience Research, eds Windhorst U., Johansson H. (Heidelberg: Springer; ), 1149\u20131198."}, {"Citation": "Khan O., Shen Y., Caon C., Bao F., Ching W., Reznar M., et al. (2005). Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis. Mult. Scler. 11 646\u2013651. 10.1191/1352458505ms1234oa", "ArticleIdList": ["10.1191/1352458505ms1234oa", "16320723"]}, {"Citation": "Kilic E., Kilic U., Reiter R. J., Bassetti C. L., Hermann D. M. (2004). Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1. J. Pineal Res. 37 247\u2013251. 10.1111/j.1600-079X.2004.00162.x", "ArticleIdList": ["10.1111/j.1600-079X.2004.00162.x", "15485550"]}, {"Citation": "Lavrnja I., Smiljanic K., Savic D., Mladenovic-Djordjevic A., Tesovic K., Kanazir S., et al. (2017). Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord. Sci. Rep. 7:2702. 10.1038/s41598-017-02638-8", "ArticleIdList": ["10.1038/s41598-017-02638-8", "PMC5457442", "28578430"]}, {"Citation": "Lee Y., Morrison B. M., Li Y., Lengacher S., Farah M. H., Hoffman P. N., et al. (2012). Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487 443\u2013448. 10.1038/nature11314", "ArticleIdList": ["10.1038/nature11314", "PMC3408792", "22801498"]}, {"Citation": "Leon J., Acuna-Castroviejo D., Sainz R. M., Mayo J. C., Tan D. X., Reiter R. J. (2004). Melatonin and mitochondrial function. Life Sci. 75 765\u2013790. 10.1016/j.lfs.2004.03.003", "ArticleIdList": ["10.1016/j.lfs.2004.03.003", "15183071"]}, {"Citation": "Long T., Yang Y., Peng L., Li Z. (2018). Neuroprotective effects of melatonin on experimental allergic encephalomyelitis mice via anti-oxidative stress activity. J. Mol. Neurosci. 64 233\u2013241. 10.1007/s12031-017-1022-x", "ArticleIdList": ["10.1007/s12031-017-1022-x", "29450696"]}, {"Citation": "Lopaschuk G. D., Ussher J. R., Folmes C. D., Jaswal J. S., Stanley W. C. (2010). Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90 207\u2013258. 10.1152/physrev.00015.2009", "ArticleIdList": ["10.1152/physrev.00015.2009", "20086077"]}, {"Citation": "Mahad D., Ziabreva I., Lassmann H., Turnbull D. (2008). Mitochondrial defects in acute multiple sclerosis lesions. Brain 131 1722\u20131735. 10.1093/brain/awn105", "ArticleIdList": ["10.1093/brain/awn105", "PMC2442422", "18515320"]}, {"Citation": "Mahad D. H., Trapp B. D., Lassmann H. (2015). Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 14 183\u2013193. 10.1016/S1474-4422(14)70256-X", "ArticleIdList": ["10.1016/S1474-4422(14)70256-X", "25772897"]}, {"Citation": "Martin M., Macias M., Escames G., Leon J., Acuna-Castroviejo D. (2000). Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J. 14 1677\u20131679. 10.1096/fj.99-0865fje", "ArticleIdList": ["10.1096/fj.99-0865fje", "10973915"]}, {"Citation": "McClelland G. B., Khanna S., Gonz\u00e1lez G. F., Butz C. E., Brooks G. A. (2003). Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system? Biochem. Biophys. Res. Commun. 304 130\u2013135. 10.1016/S0006-291X(03)00550-3", "ArticleIdList": ["10.1016/S0006-291X(03)00550-3", "12705896"]}, {"Citation": "Melamud L., Golan D., Luboshitzky R., Lavi I., Miller A. (2012). Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis. J. Neurol. Sci. 314 37\u201340. 10.1016/j.jns.2011.11.003", "ArticleIdList": ["10.1016/j.jns.2011.11.003", "22137446"]}, {"Citation": "Moffett J. R., Ross B., Arun P., Madhavarao C. N., Namboodiri M. A. A. (2007). N-acetylaspartate in the Cns: from neurodiagnostics to neurobiology. Prog. Neurobiol. 81 89\u2013131. 10.1016/j.pneurobio.2006.12.003", "ArticleIdList": ["10.1016/j.pneurobio.2006.12.003", "PMC1919520", "17275978"]}, {"Citation": "Mostert J. P., Sijens P. E., Oudkerk M., De Keyser J. (2006). Fluoxetine increases cerebral white matter Naa/Cr ratio in patients with multiple sclerosis. Neurosci. Lett. 402 22\u201324. 10.1016/j.neulet.2006.03.042", "ArticleIdList": ["10.1016/j.neulet.2006.03.042", "16644118"]}, {"Citation": "Muse E. D., Jurevics H., Toews A. D., Matsushima G. K., Morell P. (2001). Parameters related to lipid metabolism as markers of myelination in mouse brain. J. Neurochem. 76 77\u201386. 10.1046/j.1471-4159.2001.00015.x", "ArticleIdList": ["10.1046/j.1471-4159.2001.00015.x", "11145980"]}, {"Citation": "Narayanan S., De Stefano N., Francis G. S., Arnaoutelis R., Caramanos Z., Collins D. L., et al. (2001). Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J. Neurol. 248 979\u2013986. 10.1007/s004150170052", "ArticleIdList": ["10.1007/s004150170052", "11757963"]}, {"Citation": "Nashold F. E., Nelson C. D., Brown L. M., Hayes C. E. (2013). One calcitriol dose transiently increases Helios+ FoxP3+ T cells and ameliorates autoimmune demyelinating disease. J. Neuroimmunol. 263 64\u201374. 10.1016/j.jneuroim.2013.07.016", "ArticleIdList": ["10.1016/j.jneuroim.2013.07.016", "23968560"]}, {"Citation": "Olivier P., Fontaine R. H., Loron G., Van Steenwinckel J., Biran V., Massonneau V., et al. (2009). Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PloS One, 4:e7128. 10.1371/journal.pone.0007128", "ArticleIdList": ["10.1371/journal.pone.0007128", "PMC2742165", "19771167"]}, {"Citation": "Parikh S., Saneto R., Falk M. J., Anselm I., Cohen B. H., Haas R., et al. (2009). A modern approach to the treatment of mitochondrial disease. Curr. Treat. Options Neurol. 11 414\u2013430. 10.1007/s11940-009-0046-0", "ArticleIdList": ["10.1007/s11940-009-0046-0", "PMC3561461", "19891905"]}, {"Citation": "Pliss L., Hausknecht K. A., Stachowiak M. K., Dlugos C. A., Richards J. B., Patel M. S. (2013). Cerebral developmental abnormalities in a mouse with systemic Pyruvate dehydrogenase deficiency. PLoS One 8:e67473. 10.1371/journal.pone.0067473", "ArticleIdList": ["10.1371/journal.pone.0067473", "PMC3694023", "23840713"]}, {"Citation": "Pliss L., Pentney R. J., Johnson M. T., Patel M. S. (2004). Biochemical and structural brain alterations in female mice with cerebral pyruvate dehydrogenase deficiency. J. Neurochem. 91 1082\u20131091. 10.1111/j.1471-4159.2004.02790.x", "ArticleIdList": ["10.1111/j.1471-4159.2004.02790.x", "15569252"]}, {"Citation": "Rinholm J. E., Bergersen L. H. (2014). White matter lactate\u2013does it matter? Neuroscience 276 109\u2013116. 10.1016/j.neuroscience.2013.10.002", "ArticleIdList": ["10.1016/j.neuroscience.2013.10.002", "24125892"]}, {"Citation": "Saher G., Brugger B., Lappe-Siefke C., Mobius W., Tozawa R., Wehr M. C., et al. (2005). High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8 468\u2013475. 10.1038/nn1426", "ArticleIdList": ["10.1038/nn1426", "15793579"]}, {"Citation": "S\u00e1nchez-L\u00f3pez A. L., Ortiz G. G., Pacheco-Moises F. P., Mireles-Ram\u00edrez M. A., Bitzer-Quintero O. K., Delgado-Lara D. L., et al. (2018). Efficacy of melatonin on serum pro-inflammatory cytokines and oxidative stress markers in relapsing remitting multiple sclerosis. Arch. Med. Res. 49 391\u2013398. 10.1016/j.arcmed.2018.12.004", "ArticleIdList": ["10.1016/j.arcmed.2018.12.004", "30595364"]}, {"Citation": "Sandyk R. (1993). Multiple sclerosis: the role of puberty and the pineal gland in its pathogenesis. Int. J. Neurosci. 68 209\u2013225. 10.3109/00207459308994277", "ArticleIdList": ["10.3109/00207459308994277", "8063527"]}, {"Citation": "Sedel F., Bernard D., Mock D. M., Tourbah A. (2016). Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis. Neuropharmacology 110 644\u2013653. 10.1016/j.neuropharm.2015.08.028", "ArticleIdList": ["10.1016/j.neuropharm.2015.08.028", "26327679"]}, {"Citation": "Shannon R. J., Van Der Heide S., Carter E. L., Jalloh I., Menon D. K., Hutchinson P. J., et al. (2016). Extracellular N-acetylaspartate in human traumatic brain injury. J. Neurotrauma 33 319\u2013329. 10.1089/neu.2015.3950", "ArticleIdList": ["10.1089/neu.2015.3950", "PMC4761801", "26159566"]}, {"Citation": "Sharman E. H., Bondy S. C., Sharman K. G., Lahiri D., Cotman C. W., Perreau V. M. (2007). Effects of melatonin and age on gene expression in mouse CNS using microarray analysis. Neurochem. Int. 50 336\u2013344. 10.1016/j.neuint.2006.09.001", "ArticleIdList": ["10.1016/j.neuint.2006.09.001", "PMC1868445", "17118492"]}, {"Citation": "Signoretti S., Marmarou A., Tavazzi B., Lazzarino G., Beaumont A., Vagnozzi R. (2001). N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. J. Neurotrauma 18 977\u2013991. 10.1089/08977150152693683", "ArticleIdList": ["10.1089/08977150152693683", "11686498"]}, {"Citation": "Srinivasan V., Spence D. W., Pandi-Perumal S. R., Brown G. M., Cardinali D. P. (2011). Melatonin in mitochondrial dysfunction and related disorders. Int. J. Alzheimers Dis. 2011:326320. 10.4061/2011/326320", "ArticleIdList": ["10.4061/2011/326320", "PMC3100547", "21629741"]}, {"Citation": "Steinman L. (1996). Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85 299\u2013302. 10.1016/S0092-8674(00)81107-1", "ArticleIdList": ["10.1016/S0092-8674(00)81107-1", "8616884"]}, {"Citation": "Tan D. X., Manchester L. C., Terron M. P., Flores L. J., Tamura H., Reiter R. J. (2007). Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative Mt3 melatonin membrane receptor: hypothesis and significance. J. Pineal Res. 43 317\u2013320. 10.1111/j.1600-079X.2007.00513.x", "ArticleIdList": ["10.1111/j.1600-079X.2007.00513.x", "17910598"]}, {"Citation": "Tress O., Maglione M., May D., Pivneva T., Richter N., Seyfarth J., et al. (2012). Panglial gap junctional communication is essential for maintenance of myelin in the Cns. J. Neurosci. 32 7499\u20137518. 10.1523/JNEUROSCI.0392-12.2012", "ArticleIdList": ["10.1523/JNEUROSCI.0392-12.2012", "PMC6703577", "22649229"]}, {"Citation": "Wanders R. J., Waterham H. R., Ferdinandusse S. (2015). Metabolic interplay between peroxisomes and other subcellular organelles including mitochondria and the endoplasmic reticulum. Front. Cell Dev. Biol. 3:83. 10.3389/fcell.2015.00083", "ArticleIdList": ["10.3389/fcell.2015.00083", "PMC4729952", "26858947"]}, {"Citation": "Welin A. K., Svedin P., Lapatto R., Sultan B., Hagberg H., Gressens P., et al. (2007). Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr. Res. 61 153\u2013158. 10.1203/01.pdr.0000252546.20451.1a", "ArticleIdList": ["10.1203/01.pdr.0000252546.20451.1a", "17237714"]}, {"Citation": "Yool D., Montague P., Mclaughlin M., Mcculloch M. C., Edgar J. M., Nave K. A., et al. (2002). Phenotypic analysis of mice deficient in the major myelin protein Mobp, and evidence for a novel Mobp isoform. Glia 39 256\u2013267. 10.1002/glia.10103", "ArticleIdList": ["10.1002/glia.10103", "12203392"]}]}], "History": [{"Year": "2018", "Month": "11", "Day": "26"}, {"Year": "2019", "Month": "2", "Day": "8"}, {"Year": "2019", "Month": "3", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "16", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "2", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["30873027", "PMC6403148", "10.3389/fphar.2019.00147"]}}]}